litlas
ログインアカウント作成

Curtis A. Hanson

1990–2025 年に発表

別表記
Curtis A Hanson
136
論文数
20,091
被引用数
86
h 指数
130
i10 指数

被引用数

Curtis A. Hanson の年別被引用数1983 年: 被引用 1 件1986 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 3 件1994 年: 被引用 4 件1995 年: 被引用 3 件1996 年: 被引用 6 件1997 年: 被引用 2 件1998 年: 被引用 6 件1999 年: 被引用 2 件2000 年: 被引用 10 件2001 年: 被引用 17 件2002 年: 被引用 28 件2003 年: 被引用 34 件2004 年: 被引用 34 件2005 年: 被引用 28 件2006 年: 被引用 32 件2007 年: 被引用 63 件2008 年: 被引用 87 件2009 年: 被引用 120 件2010 年: 被引用 123 件2011 年: 被引用 115 件2012 年: 被引用 146 件2013 年: 被引用 162 件2014 年: 被引用 176 件2015 年: 被引用 186 件2016 年: 被引用 173 件2017 年: 被引用 158 件2018 年: 被引用 177 件2019 年: 被引用 474 件2020 年: 被引用 708 件2021 年: 被引用 608 件2022 年: 被引用 577 件2023 年: 被引用 314 件2024 年: 被引用 586 件2025 年: 被引用 203 件2026 年: 被引用 4 件1984〜1985 年は被引用が無いため表示していません1987〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,625 件、この内訳の 28.5%イタリア: 引用元論文 566 件、この内訳の 9.9%ドイツ: 引用元論文 403 件、この内訳の 7.1%イギリス: 引用元論文 356 件、この内訳の 6.3%フランス: 引用元論文 353 件、この内訳の 6.2%スペイン: 引用元論文 253 件、この内訳の 4.4%カナダ: 引用元論文 189 件、この内訳の 3.3%中国: 引用元論文 148 件、この内訳の 2.6%オランダ: 引用元論文 146 件、この内訳の 2.6%スイス: 引用元論文 143 件、この内訳の 2.5%オーストラリア: 引用元論文 136 件、この内訳の 2.4%スウェーデン: 引用元論文 117 件、この内訳の 2.1%
0%28.5%その他 22.1%

機関

分野

  • Medicine87.8%
  • Biochemistry, Genetics and Molecular Biology7.2%
  • Immunology and Microbiology3.9%
  • Computer Science0.3%
  • Mathematics0.2%
  • Engineering0.1%
  • その他0.5%

トピック

  • Myeloproliferative Neoplasms: Diagnosis and Treatment13.9%
  • Acute Myeloid Leukemia Research11%
  • Chronic Lymphocytic Leukemia Research9.4%
  • Lymphoma Diagnosis and Treatment8.1%
  • Chronic Myeloid Leukemia Treatments5.2%
  • Kruppel-like factors research5.2%
  • その他47.2%

共著者

全論文

検索で開く
  1. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    著者: Tait D. Shanafelt, Xin V. Wang, Neil E. Kay, Curtis A. Hanson, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong C. Zhang, Steven Coutré, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman - New England Journal of Medicine 2019 被引用: 738

  2. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

    著者: Tait D. Shanafelt, Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong Christine Zhang, Steven Coutré, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman, Neil E. Kay - Blood 2022 被引用: 237

  3. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

    著者: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Mythri Mudireddy, Carmela Mannarelli, Maura Nicolosi, Annalisa Pacilli, Animesh Pardanani, Elisa Rumi, Vittorio Rosti, Curtis A. Hanson, Francesco Mannelli, Rhett P. Ketterling, Naseema Gangat, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi, Ayalew Tefferi - Journal of Clinical Oncology 2017 被引用: 532

  4. DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    著者: Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Geeta George, Kebede H. Begna, Susan M. Schwager, Daniel Van Dyke, Curtis A. Hanson, Wenting Wu, Animesh Pardanani, Francisco Cervantes, Francesco Passamonti, Ayalew Tefferi - Journal of Clinical Oncology 2010 被引用: 1,032

  5. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

    著者: Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy M. Finke, Emnet A Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Jüergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi - Blood 2014 被引用: 727

  6. Mutation‐enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

    著者: Ayalew Tefferi, Paola Guglielmelli, Terra L. Lasho, Giacomo Coltro, Christy M. Finke, Giuseppe Gaetano Loscocco, Benedetta Sordi, Natasha Szuber, Giada Rotunno, Annalisa Pacilli, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi - British Journal of Haematology 2020 被引用: 221

  7. GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

    著者: Ayalew Tefferi, Paola Guglielmelli, Maura Nicolosi, Francesco Mannelli, Mythri Mudireddy, Niccolò Bartalucci, Christy M. Finke, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Kebede H. Begna, Naseema Gangat, Animesh Pardanani, Alessandro M. Vannucchi - Leukemia 2018 被引用: 294

  8. One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

    著者: Ayalew Tefferi, Terra L. Lasho, Thitina Jimma, Christy M. Finke, Naseema Gangat, Rakhee Vaidya, Kebede H. Begna, Aref Al‐Kali, Rhett P. Ketterling, Curtis A. Hanson, Animesh Pardanani - Mayo Clinic Proceedings 2012 被引用: 249

  9. Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    著者: Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, Christy M. Finke, Giada Rotunno, Yoseph Elala, Annalisa Pacilli, Curtis A. Hanson, Alessandro Pancrazzi, Rhett P. Ketterling, Carmela Mannarelli, Daniela Barraco, Tiziana Fanelli, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi - Blood Advances 2016 被引用: 301

  10. Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

    著者: Natasha Szuber, Rangit Vallapureddy, Domenico Penna, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi - American Journal of Hematology 2018 被引用: 90

  11. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment

    著者: Giovanni Barosi, Ruben A. Mesa, J. Thiele, Francisco Cervantes, Peter J. Campbell, Srđan Verstovšek, Brigitte Dupriez, Ross L. Levine, Francesco Passamonti, Jason Gotlib, John T. Reilly, Alessandro M. Vannucchi, Curtis A. Hanson, Lawrence A. Solberg, Attilio Orazi, Ayalew Tefferi - Leukemia 2007 被引用: 496

  12. A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

    著者: Ayalew Tefferi, Terra L. Lasho, Kebede H. Begna, Mrinal M. Patnaik, Darci Zblewski, Christy M. Finke, Rebecca R. Laborde, Emnet A Wassie, Lauren Schimek, Curtis A. Hanson, Naseema Gangat, Xiaolin Wang, Animesh Pardanani - New England Journal of Medicine 2015 被引用: 322

  13. A globally applicable “triple A” risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte count

    著者: Ayalew Tefferi, Giuseppe Gaetano Loscocco, Faiqa Farrukh, Natasha Szuber, Francesco Mannelli, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Valerio De Stefano, Alessandra Carobbio, Tiziano Barbui, Paola Guglielmelli, Naseema Gangat, Alessandro M. Vannucchi - American Journal of Hematology 2023 被引用: 38

  14. Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients

    著者: Maura Nicolosi, Mythri Mudireddy, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Animesh Pardanani, Ayalew Tefferi - Leukemia 2018 被引用: 81

  15. Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    著者: Tiziano Barbui, Jüergen Thiele, Francesco Passamonti, Elisa Rumi, Emanuela Boveri, Marco Ruggeri, Francesco Rodeghiero, Emanuele S.G. dʼAmore, Maria Luigia Randi, Irene Bertozzi, Filippo Marino, Alessandro M. Vannucchi, Elisabetta Antonioli, Valentina Carrai, Heinz Gisslinger, Veronika Buxhofer‐Ausch, Leonhard Müllauer, Alessandra Carobbio, Andrea Gianatti, Naseema Gangat, Curtis A. Hanson, Ayalew Tefferi - Journal of Clinical Oncology 2011 被引用: 538

  16. A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

    著者: Andy C. Rawstron, Claudia Fazi, Andreas Agathangelidis, Neus Villamor, Rémi Letestu, Josep Nomdedéu, Carlos Palacio, Olga Stehlíková, K-A Kreuzer, Stuart Liptrot, David O’Brien, Ruth M. de Tute, Iuri Marinov, Mathieu Hauwel, Martin Špaček, Johan A. Dobber, Arnon P. Kater, Peter Gambell, Asha Soosapilla, Gerard Lozanski, Gabriele Brachtl, Ke Lin, Justin C. Boysen, Curtis A. Hanson, Jeffrey L. Jorgensen, Maryalice Stetler‐Stevenson, Constance M. Yuan, H. Elizabeth Broome, Laura Z. Rassenti, Fiona E. Craig, Julio Delgado, Carol Moreno, Francesc Bosch, A Egle, Michael Doubek, Šárka Pospı́šilová, Stephen P. Mulligan, David Westerman, Catherine Sanders, Ryan Emerson, Harlan Robins, Ilan Kirsch, Tait D. Shanafelt, Andrew R. Pettitt, Thomas J. Kipps, William G. Wierda, Florence Cymbalista, Michael Hallek, Peter Hillmen, Emili Montserrat, Paolo Ghia - Leukemia 2015 被引用: 241

  17. 3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

    著者: Natasha Szuber, Mythri Mudireddy, Maura Nicolosi, Domenico Penna, Rangit Vallapureddy, Terra L. Lasho, Christy M. Finke, Kebede H. Begna, Michelle A. Elliott, C. Christopher Hook, Alexandra P. Wolanskyj, Mrinal M. Patnaik, Curtis A. Hanson, Rhett P. Ketterling, Shireen Sirhan, Animesh Pardanani, Naseema Gangat, Lambert Busque, Ayalew Tefferi - Mayo Clinic Proceedings 2019 被引用: 163

  18. The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

    著者: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, J Score, C Mannarelli, Alessandro Pancrazzi, Flavia Biamonte, Animesh Pardanani, Katerina Zoi, A. Reiter, Andrew Duncombe, Tiziana Fanelli, Daniela Pietra, Elisa Rumi, Christy M. Finke, Naseema Gangat, Rhett P. Ketterling, Ryan A. Knudson, Curtis A. Hanson, Alberto Bosi, Arturo Pereira, Rossella Manfredini, Francisco Cervantes, G. Barosi, M. Cazzola, Nicholas C.P. Cross, A. M. Vannucchi, Ayalew Tefferi - Leukemia 2014 被引用: 308

  19. Validation of the revised international prognostic score of thrombosis for essential thrombocythemia (IPSET‐thrombosis) in 585 Mayo clinic patients

    著者: Mahnur Haider, Naseema Gangat, Terra L. Lasho, Ahmed Kamel Abou Hussein, Yoseph Elala, Curtis A. Hanson, Ayalew Tefferi - American Journal of Hematology 2016 被引用: 145

  20. Diffuse large B‐cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients

    著者: Sameer A. Parikh, Kari G. Rabe, Timothy G. Call, Clive S. Zent, Thomas M. Habermann, Wei Ding, José F. Leis, Susan M. Schwager, Curtis A. Hanson, William R. Macon, Neil E. Kay, Susan L. Slager, Tait D. Shanafelt - British Journal of Haematology 2013 被引用: 222

  21. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance

    著者: Mrinal M. Patnaik, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Janice M. Hodnefield, Ryan A. Knudson, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi - American Journal of Hematology 2012 被引用: 151

  22. One thousand patients with essential thrombocythemia: the Mayo Clinic experience

    著者: Naseema Gangat, Omer Karrar, Aref Al‐Kali, Kebede H. Begna, Michelle A. Elliott, Alexandra P. Wolanskyj, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi - Blood Cancer Journal 2024 被引用: 46

  23. ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients

    著者: Mrinal M. Patnaik, Raphaël Itzykson, Terra L. Lasho, Olivier Kosmider, Christy M. Finke, Curtis A. Hanson, Ryan A. Knudson, Rhett P. Ketterling, Ayalew Tefferi, Éric Solary - Leukemia 2014 被引用: 282

  24. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

    著者: Sonia Cerquozzi, Daniela Barraco, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi - Blood Cancer Journal 2017 被引用: 147